Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2009, Article ID 437284, 13 pages
http://dx.doi.org/10.1155/2009/437284
Research Article

Molecularly Characterised Xenograft Tumour Mouse Models: Valuable Tools for Evaluation of New Therapeutic Strategies for Secondary Liver Cancers

1Department of Pathobiology, Institute of Virology, University of Veterinary Medicine, Veterinaerplatz 1, 1210 Vienna, Austria
2Department of Data collection, Statistics, and Risk assessment, Austrian Agency for Health and Food Safety (AGES), Spargelfeldstrasse 191, 1226 Vienna, Austria
3Department of Biomedical Sciences, Institute of Animal Breeding and Genetics, University of Veterinary Medicine, Veterinaerplatz 1, 1210 Vienna, Austria
4VetOMICS, University of Veterinary Medicine, Veterinaerplatz 1, 1210 Vienna, Austria
5Department of Surgery, Medical University Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria
6Department of Pathology, Medical University of Graz, Auenbruggerplatz 25, 8036 Graz, Austria
7Division of Molecular and Experimental Surgery, Department of Surgery, University of Erlangen-Nürnberg, Schwabachanlage 10, 91054 Erlangen, Germany

Received 10 July 2008; Revised 5 November 2008; Accepted 19 December 2008

Academic Editor: Lisa Wiesmuller

Copyright © 2009 Daniela Mischek et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. A. Khan, B. R. Davidson, R. Goldin et al., “Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document,” Gut, vol. 51, supplement 6, pp. vi1–vi9, 2002. View at Publisher · View at Google Scholar
  2. M. Lise, P. Pilati, P. Da Pian, S. Mocellin, D. Nitti, and S. Corazzino, “Treatment options for liver metastases from colorectal cancer,” Journal of Experimental & Clinical Cancer Research, vol. 22, supplement 4, pp. 149–156, 2003. View at Google Scholar
  3. M. Lise, S. Mocellin, P. Pilati, and D. Nitti, “Colorectal liver metastasis: towards the integration of conventional and molecularly targeted therapeutic approaches,” Frontiers in Bioscience, vol. 10, pp. 3042–3057, 2005. View at Publisher · View at Google Scholar
  4. P. Saletti and F. Cavalli, “Metastatic colorectal cancer,” Cancer Treatment Reviews, vol. 32, no. 7, pp. 557–571, 2006. View at Publisher · View at Google Scholar
  5. D. A. Tuveson and T. Jacks, “Technologically advanced cancer modeling in mice,” Current Opinion in Genetics and Development, vol. 12, no. 1, pp. 105–110, 2002. View at Publisher · View at Google Scholar
  6. D. A. Tuveson, L. Zhu, A. Gopinathan et al., “Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinoma,” Cancer Research, vol. 66, no. 1, pp. 242–247, 2006. View at Publisher · View at Google Scholar
  7. M. Kilian, J. I. Gregor, I. Heukamp et al., “Impact of taurolidin and octreotide on liver metastasis and lipid peroxidation after laparoscopy in chemical induced ductal pancreatic cancer,” Investigational New Drugs, vol. 23, no. 2, pp. 157–164, 2005. View at Publisher · View at Google Scholar
  8. V. N. Anisimov, S. V. Ukraintseva, and A. I. Yashin, “Cancer in rodents: does it tell us about cancer in humans?” Nature Reviews Cancer, vol. 5, no. 10, pp. 807–819, 2005. View at Publisher · View at Google Scholar
  9. A. Rangarajan and R. A. Weinberg, “Comparative biology of mouse versus human cells: modelling human cancer in mice,” Nature Reviews Cancer, vol. 3, no. 12, pp. 952–959, 2003. View at Publisher · View at Google Scholar
  10. Y. Chen, K.-J. Chang, L.-H. Hwang, C.-N. Chen, and S.-H. Tseng, “Establishment and characterization of a rectal cancer model in mice: application to cytokine gene therapy,” International Journal of Colorectal Disease, vol. 17, no. 6, pp. 388–395, 2002. View at Publisher · View at Google Scholar
  11. G. D. Paine-Murrieta, C. W. Taylor, R. A. Curtis et al., “Human tumor models in the severe combined immune deficient (scid) mouse,” Cancer Chemotherapy and Pharmacology, vol. 40, no. 3, pp. 209–214, 1997. View at Publisher · View at Google Scholar
  12. F. X. Sun, Z. Y. Tang, K. D. Liu et al., “Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues,” International Journal of Cancer, vol. 66, no. 2, pp. 239–243, 1996. View at Publisher · View at Google Scholar
  13. X. Y. Fu, J. M. Besterman, A. Monosov, and R. M. Hoffman, “Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 20, pp. 9345–9349, 1991. View at Publisher · View at Google Scholar
  14. C. Armengol, G. Tarafa, L. Boix et al., “Orthotopic implantation of human hepatocellular carcinoma in mice: analysis of tumor progression and establishment of the BCLC-9 cell line,” Clinical Cancer Research, vol. 10, no. 6, pp. 2150–2157, 2004. View at Publisher · View at Google Scholar
  15. Y.-S. Gao, X.-P. Chen, K.-Y. Li, and Z.-D. Wu, “Nude mice model of human hepatocellular carcinoma via orthotopic implantation of histologically intact tissue,” World Journal of Gastroenterology, vol. 10, no. 21, pp. 3107–3111, 2004. View at Google Scholar
  16. G. Carlsson, B. Gullberg, and L. Hafström, “Estimation of liver tumor volume using different formulas—an experimental study in rats,” Journal of Cancer Research and Clinical Oncology, vol. 105, no. 1, pp. 20–23, 1983. View at Publisher · View at Google Scholar
  17. V. V. Kalinichenko, M. L. Major, X. Wang et al., “Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor,” Genes & Development, vol. 18, no. 7, pp. 830–850, 2004. View at Publisher · View at Google Scholar
  18. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar
  19. S. Hammarström, “The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues,” Seminars in Cancer Biology, vol. 9, no. 2, pp. 67–81, 1999. View at Publisher · View at Google Scholar
  20. P. G. Chu and L. M. Weiss, “Keratin expression in human tissues and neoplasms,” Histopathology, vol. 40, no. 5, pp. 403–439, 2002. View at Publisher · View at Google Scholar
  21. A. Li, M. L. Varney, and R. K. Singh, “Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials,” Clinical Cancer Research, vol. 7, no. 10, pp. 3298–3304, 2001. View at Google Scholar
  22. T. H. Vu and Z. Werb, “Matrix metalloproteinases: effectors of development and normal physiology,” Genes & Development, vol. 14, no. 17, pp. 2123–2133, 2000. View at Publisher · View at Google Scholar
  23. W. G. Stetler-Stevenson, “Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention,” The Journal of Clinical Investigation, vol. 103, no. 9, pp. 1237–1241, 1999. View at Publisher · View at Google Scholar
  24. M. Egeblad and Z. Werb, “New functions for the matrix metalloproteinases in cancer progression,” Nature Reviews Cancer, vol. 2, no. 3, pp. 161–174, 2002. View at Publisher · View at Google Scholar
  25. C. E. Brinckerhoff, J. L. Rutter, and U. Benbow, “Interstitial collagenases as markers of tumor progression,” Clinical Cancer Research, vol. 6, no. 12, pp. 4823–4830, 2000. View at Google Scholar
  26. U. Benbow, M. P. Schoenermark, T. I. Mitchell et al., “A novel host/tumor cell interaction activates matrix metalloproteinase I and mediates invasion through type I collagen,” The Journal of Biological Chemistry, vol. 274, no. 36, pp. 25371–25378, 1999. View at Publisher · View at Google Scholar
  27. P. Bassed, J. P. Bellocq, C. Wolf et al., “A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas,” Nature, vol. 348, no. 6303, pp. 699–704, 1990. View at Publisher · View at Google Scholar
  28. L. T. Soumaoro, H. Uetake, Y. Takagi et al., “Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasis,” Diseases of the Colon & Rectum, vol. 49, no. 3, pp. 392–398, 2006. View at Publisher · View at Google Scholar
  29. C. Metzl, D. Mischek, B. Salmons, W. H. Günzburg, M. Renner, and D. Portsmouth, “Tissue- and tumor-specific targeting of murine leukemia virus-based replication-competent retroviral vectors,” Journal of Virology, vol. 80, no. 14, pp. 7070–7078, 2006. View at Publisher · View at Google Scholar
  30. Y. Iwasaki, M. Ueda, T. Yamada et al., “Gene therapy of liver tumors with human liver-specific nanoparticles,” Cancer Gene Therapy, vol. 14, no. 1, pp. 74–81, 2007. View at Publisher · View at Google Scholar